Treatment Advances in EBV Related Lymphoproliferative Diseases

Epstein Barr virus (EBV) can affect 90% of the human population. It can invade B lymphocytes, T lymphocytes and natural killer cells of the host and remain in the host for life. The long latency and reactivation of EBV can cause malignant transformation, leading to various lymphoproliferative diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Kebing, Yin, Ting, Yu, Min, Chen, Zhiwei, Zhou, Yulan, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063483/
https://www.ncbi.nlm.nih.gov/pubmed/35515118
http://dx.doi.org/10.3389/fonc.2022.838817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063483/
https://www.ncbi.nlm.nih.gov/pubmed/35515118
http://dx.doi.org/10.3389/fonc.2022.838817

Ejemplares similares